e-Drug3D

2177

DOXECITINE


INN
DOXECITINE

cas 951-77-9
CLASS

METABOLISM
PYRIMIDINE NUCLEOSIDE
TREATMENT OF THYMIDINE KINASE 2 DEFICIENCY (TK2D)
INCORPORATED INTO SKELETAL MUSCLE MITOCHONDRIAL DEOXYRIBONUCLEIC ACID (DNA)

ROUTE (list)

ORAL

ATC code

A16AX29

PK parameters

Tmax 2 HOUR
PPB 10 PERCENT
t1/2 1 HOUR

Target

TARGET DNA

DrugCentral

-

Download SDF file Cytidine, 2-deoxy-

Formula:
C9H13N3O4

Calculated chemical properties:

MW 227.22
NB_atoms 16
XLogP -1.53
PSA 105.781
NB_HD 4
NB_HA 7
fsp3 0.56
Lipinski(0=no;1=yes) 1

FDA
NDA 219792 (label) INN (DOXECITINE ; DOXRIBTIMINE) KYGEVVI (UCB INC) APPROVAL= AP YEAR= 2025 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL